Stryker (SYK) Q3 2025 Earnings
Stryker reported Q3 2025 revenue of $6.1B (+10.2% YoY), beat analyst consensus of $6.0B by $12.4M. Diluted EPS came in at $3.19 (+11.1% YoY), beat the $3.13 consensus by $0.06. Stryker reports across 2 business segments, led by MedSurg and Neurotechnology and Orthopaedics.
Financial Snapshot
Trailing eight quarters through Q3 2025
Q3 2025 Earnings FAQ
Common questions about Stryker's Q3 2025 earnings report.
Stryker (SYK) reported Q3 2025 earnings on October 30, 2025 after market close.
Stryker reported revenue of $6.1B and diluted EPS of $3.19 for Q3 2025.
Revenue beat the consensus estimate of $6.0B by $12.4M. EPS beat the consensus estimate of $3.13 by $0.06.
Compared to the same quarter a year prior, revenue grew 10.2% from $5.5B a year earlier and diluted EPS grew 11.1% from $2.87.
You can read the 10-Q periodic report (0000310764-25-000129) directly on SEC EDGAR. The filing index links above go to sec.gov.